Trial intelligence / Profile preview

Subcutaneous BNP in Heart Failure

NCT00252187Phase 2Completed

Start
Jan 2000
Primary completion
Jul 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of nesiritide in heart failure (HF), cardiomyopathy. Started Jan 2000; status: completed.

02

Drugs

nesiritide
03

Conditions

heart failure (HF)cardiomyopathy

Beyond the preview

Go deeper on NCT00252187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00252187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call